Stocks were led higher by tech on Friday, as bets on a September rate cut were boosted after Trump nominated his top economic adviser, Stephen Miran, to fill a vacant seat on the Fed board
In a week with around 30% of the ASX200 reporting, we take a look at some of the best performers of the year so far and give you the context of where they are, where they are valued and what to focus on
Telix’s stock has been pummeled after announcing an SEC inquiry— a routine regulatory request, followed by a routine opportunistic law firm “investigation” are simply the cost of success in a high-profile sector, not a red flag
Australian shares eased on Friday, with the S&P/ASX 200 down 0.2% or 20.2 points to 8811.20 at 2:05pm AEST, though the index remains on track for its first weekly gain in three weeks, up 1.7%. Market sentiment softened as US President Donald Trump’s sweeping new tariffs—impacting over 90 countries—took effect, lifting the average US import rate to over 17%, the highest since the Great Depression.
In this week’s episode of Bulls vs Bears from MPC Markets, the Mark & Jonathan dive into recent market highlights, commodity trends, stock picks, and geopolitical impacts on trading. They share insights from media appearances, discuss Trump-era tariffs, and provide a bullish outlook for the coming week amid US earnings season. Key focuses include copper, silver, Tesla, and emerging AI influences in markets.
Stocks closed slightly lower after clawing back losses late into the close as investors weighed reports of shake up at the Federal Reserve and ongoing strength in tech stocks.
When biotech headlines scream “SEC subpoena,” panic can quickly outweigh perspective. But beneath the sell-off frenzy surrounding Telix Pharmaceuticals’ recent regulatory disclosure lies a compelling opportunity masked by fear.
Telix’s stock has been pummeled after announcing an SEC inquiry— a routine regulatory request, followed by a routine opportunistic law firm “investigation” are simply the cost of success in a high-profile sector, not a red flag
The S&P/ASX 200 Index slipped 0.2% or 16.4 points to 8827.30 by 2:05pm AEST on Thursday, easing after a record close in the previous session. Losses in healthcare and financials outweighed gains in technology and retail as markets digested fresh US semiconductor tariffs announced by President Donald Trump.
Anticipating next week’s company earnings and economic figures.
Stay informed on the latest financial updates and trends with MPC Markets
Anticipating next week’s company earnings and economic figures.
Stay informed on the latest financial updates and trends with MPC Markets
Stocks floated higher overnight as Trump/Apple announcement fuelled a tech rally and investors cheered mostly bullish quarterly results.
The Australian sharemarket surged to a record high on Wednesday, driven by broad gains across sectors, particularly materials and energy. The S&P/ASX 200 rose 0.6% to 8823.30 by 2:10pm AEST, having touched an intraday record of 8824 earlier in the session.
Barton Gold (BGD) is an ASX, OTCQB and Frankfurt Stock Exchange listed Australian gold developer targeting future gold production of 150,000oz annually, with ~1.6Moz Au JORC Mineral Resources (52.3Mt @ 0.94 g/t Au), multiple advanced exploration projects and brownfield mines, and 100% ownership of the only regional gold mill in the renowned central Gawler Craton of South Australia.
